Degron Therapeutics vs Kite Pharma
Degron Therapeutics vs Kite Pharma, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and Kite Pharma on 66/100.
Where each one leads
Degron Therapeutics
Leads on none of the measures we hold for both companies.
Kite Pharma
- our overall score: 66/100 against 62/100
- agent readiness: 35/100 against 27/100
- domain rating: 62/100 against 24/100
- funding raised: $421M against $40.0M
At a glance
| Measure | Degron Therapeutics | Kite Pharma |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | Biotechnology company developing and commercializing cell therapies for cancer treatment. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2009 |
| Headquarters | San Diego, USA | Santa Monica, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Degron Therapeutics | Kite Pharma |
|---|---|---|
| Employees | 24 | Not published |
| Total funding | $40.0M | $421M |
| Latest round | Series A Extension | Venture |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,380 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | Kite Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 66/100 |
| Traction | Not published | 40/100 |
| Team | 24/100 | 80/100 |
| Search visibility | 57/100 | 15/100 |
| Quality | Not published | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 24/100 | 62/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | Kite Pharma |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| Frameworks | Not detected | Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Degron Therapeutics vs Kite Pharma: common questions
Which is better, Degron Therapeutics or Kite Pharma?
On our 0-100 score Kite Pharma rates higher (66/100 against 62/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and Kite Pharma compare on the numbers?
Kite Pharma leads on our overall score (66/100 against 62/100), agent readiness (35/100 against 27/100), domain rating (62/100 against 24/100), funding raised ($421M against $40.0M).
Read the full Degron Therapeutics review and pricing or the Kite Pharma review and pricing. You can also browse other Degron Therapeutics alternatives we track.